111103 ⎘
ssRNA viruses negative-sense; Details; Rhabdoviridae; Vesiculovirus, e.g. vesicular stomatitis Indiana virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
TARGETING VECTOR, PREPARATION METHOD THEREFOR AND USE THEREOF
#2THERAPEUTIC RECOMBINANT VIRUSES
#3Mutated Glycoprotein of Vesicular Stomatitis Virus
#4METHOD FOR TREATMENT OF TUMOR BY USING RECOMBINANT ONCOLYTIC VIRUS IN COMBINATION WITH SMALL-MOLECULE ANTICANCER DRUG
#5SELF-REPLICATING RNA VACCINES AND METHODS OF USE
#6PROTEIN-BASED NANOPARTICLE FOR SELF-PACKAGING AND DELIVERING MRNA, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION
#7EXTRACELLULAR VESICLES COMPRISING SMALL INTERFERING RNA
#8MODIFIED RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
#9MODIFIED VARICELLA ZOSTER VIRUS GLYCOPROTEIN E PROTEINS
#10Dual-Action Recombinant Vesicular Stomatitis Virus (RVSV)-Based Vaccine (DAV) Against COVID-19 and Influenza Viruses
#11LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST
#12MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE
#13MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#14LYMPHOCYTE TARGETED LENTIVIRAL VECTORS
#15METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#16PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
#17Mutated Glycoprotein of Vesicular Stomatitis Virus
#18Mutated Glycoprotein of Vesicular Stomatitis Virus
#19RECOMBINANT ONCOLYTIC VIRUS AND USE THEREOF
#20COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER
#21Rapid Acting Vaccine Against Nipah Virus
#22RECOMBINANT LIVE ATTENUATED RSV VACCINE STRAIN AND PRODUCTION METHOD THEREFOR
#23LENTIVIRAL VECTOR
#24Viral Vaccines
#25COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#26CYTOMEGALOVIRUS VECTORS AND METHODS OF USE
#27SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME
#28CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS
#29ENGINEERED EXTRACELLULAR VESICLES WITH IMPROVED CARGO DELIVERY
#30RECOMBINANT BACULOVIRUSES, VACCINE COMPOSITIONS THAT COMPRISE IT, AND METHODS FOR INDUCING AN IMMUNE RESPONSE
#31ONCOLYTIC VIRUS AND USE THEREOF
#32SELF-REPLICATING RNA MOLECULES AND APPLICATION THEREOF
#33HEPATITIS B VIRUS ANTIVIRUS (HBV-ANTIVIRUS) COMPOSITIONS AND METHODS OF USE
#34VIRAL VECTOR PRODUCTION SYSTEM
#35VIRAL-LIKE PARTICLES FOR THE TREATMENT OR PREVENTION OF AN INFECTION BY A CORONAVIRIDAE VIRUS
#36COMPOSITIONS AND METHODS FOR MULTIVALENT SURFACE DISPLAY ON ENVELOPED PARTICLES
#37ARMED CHIMERIC ONCOLYTIC VIRUSES
#38USE OF CD4-TARGETED VIRAL VECTORS
#39METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#40Mutated glycoprotein of vesicular stomatitis virus
#41Mutated glycoprotein of vesicular stomatitis virus
#42Mutated glycoprotein of vesicular stomatitis virus
#43Mutated glycoprotein of vesicular stomatitis virus
#44PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
#45AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION
#46ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE
#47ONCOLYTIC VIRUS AND USE THEREOF
#48Virus-like Particles with Programmable Tropism and Methods of Use Thereof for Delivery to Cells
#49Minimal Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
#50Lymphocyte targeted lentiviral vectors
#51ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES
#52Mutated glycoprotein of vesicular stomatitis virus
#53COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#54VIRAL VECTORS AND USES THEREOF
#55MODULAR VIRAL GENOMES AND METHODS OF PRODUCING THE SAME
#56TREATMENT OF CANCER ASSOCIATED WITH DYSREGULATED NOVEL OPEN READING FRAME PRODUCTS
#57METHODS AND MATERIALS FOR TREATING CANCER
#58REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES
#59IMPROVED GENERATION OF LENTIVIRAL VECTORS FOR T CELL TRANSDUCTION USING COCAL ENVELOPE
#60Pseudotyped viral particles, compositions comprising the same, and uses thereof
#61Production of High Titer Recombinant Vesicular Stomatitis Virus in Suspension Cell Culture
#62Protein enriched microvesicles and methods of making and using the same
#63ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS
#64PSEUDOTYPED VIRUSES CONFIGURED TO EXPRESS CAR IN T-CELLS
#65BLOCKADE OF IFN SIGNALING DURING CANCER VACCINATION
#66METHODS FOR T CELL TRANSDUCTION
#67COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES
#68SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
#69TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF
#70Recombinant RSV live vaccine strain and the preparing method thereof
#71SYSTEMS AND METHODS FOR PROTEIN EXPRESSION
#72FUSOGENIC PARTICLES AND RELATED METHODS FOR DELIVERING THERAPEUTIC AGENTS TO CELLS
#73MUTANT VSV ECTODOMAIN POLYPEPTIDE AND USES THEREOF
#74MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES
#75CELL-STORED BARCODED DEEP MUTATIONAL SCANNING LIBRARIES AND USES OF THE SAME
#76NON-REPLICATING VIRUS-DERIVED PARTICLES AND USES THEREOF
#77ONCOLYTIC RHABDOVIRUS
#78Methods and constructs for production of lentiviral vector
#79Protein enriched microvesicles and methods of making and using the same
#80Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen
#81NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS
#82Mutated glycoprotein of vesicular stomatitis virus
#83Replication-competent vesicular stomatitis viruses
#84MODIFIED VSV-G AND VACCINES THEREOF
#85Antiviral peptide and use thereof
#86Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#87Transgenic VERO-CD4/CCR5 cell line
#88Methods and compositions for protein delivery
#89Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#90Antiviral peptide and use therefor
#91Gene vector
#92ONCOLYTIC RHABDOVIRUS
#93Replication-competent vesicular stomatitis viruses
#94Cocal vesiculovirus envelope pseudotyped retroviral vectors
#95Transgenic Vero-CD4/CCR5 cell line
#96LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#97ONCOLYTIC RHABDOVIRUS
#98Replication-competent vesicular stomatitis viruses
#99Protein enriched microvesicles and methods of making and using the same
#100Attenuated recombinant vesicular stomatitis viruses comprising modified matrix proteins
#101Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
#102Replication-competent VSV-HIV Env vaccines
#103Recombinant isfahan viral vectors
#104Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
#105Method of making polyethylene glycol-modified mammalian erythropoietin in a transgenic chicken
#106Pseudotyped lentiviral vectors
#107Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#108ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#109Method for producing enveloped viruses
#110Methods and compositions for protein delivery
#111Modified matrix proteins of vesicular stomatitis virus
#112Non-replicating virus-derived particles and uses thereof
#113Gene vector
#114Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#115Replication-competent vesicular stomatitis viruses
#116Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins
#117Lentiviral gene transfer vectors and their medicinal applications
#118Direct protein delivery with engineered microvesicles
#119Neuron-specific retrograde transport vector
#120Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#121HUMAN ANTIBODIES AGAINST RABIES AND USES THEREOF
#122Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#123Direct protein delivery with engineered microvesicles
#124Lentiviral gene transfer vectors and their medicinal applications
#125Retrograde transport viral vector system having envelope comprising fused glycoprotein
#126Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#127COCAL VESICULOVIRUS ENVELOPE PSEUDOTYPED RETROVIRAL VECTORS
#128ATTENUATED VACCINES FOR NON-SEGMENTED NEGATIVE SENSE RNA VIRUSES
#129CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
#130LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#131Methods and compositions for protein delivery
#132Oncolytic rhabdovirus
#133IL23 MODIFIED VIRAL VECTOR FOR RECOMBINANT VACCINES AND TUMOR TREATMENT
#134Human antibodies against rabies and uses thereof
#135Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#136METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#137Lentiviral gene transfer vectors and their medicinal applications
#138Mutant viruses and uses thereof
#139NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#140TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#141Compositions and methods of use of an oncolytic vesicular stomatitis virus
#142Recombinant viruses comprising the membrane-proximal domain of VSV G protein
#143ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#144Gene vector
#145Pseudotyped retroviral vectors and methods of use thereof
#146Methods for the propagation of modified influenza viruses in embryonated eggs
#147Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof
#148METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS
#149Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase
#150TRANSGENIC AVIAN WHICH HAS FOREIGN GENE CONTAINING SEQUENCE ENCODING FELINE-DERIVED PROTEIN AND METHOD FOR PRODUCTION THEREOF
#151Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#152Human antibodies against rabies and uses thereof
#153Protein Delivery System
#154cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses
#155Infectious recombinant paramyxovirus from antigenomic cDNA
#156Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#157ONCOLYTIC VIRUS
#158Mutant vesicular stomatitis viruses and uses thereof
#159Lentiviral apoe2 gene therapy
#160Paramyxovirus-derived RNP
#161Negative strand RNA virus replicon
#162Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
#163Targeting viruses using a modified sindbis glycoprotein
#164Recombinant baculoviral vector containing protein transduction domain gene
#165Recombinant mutants of rhabdovirus and methods of use thereof
#166Heat shock protein-based vaccines and immunotherapies
#167Methods for purifying viral particles for gene therapy
#168Antigen presenting system and methods for activation of T-cells
#169Methods and interferon deficient substrates for the propagation of viruses
#170Pseudotyped lentiviral vectors and uses thereof